Hormones and Cancer

321 papers and 8.1k indexed citations i.

About

The 321 papers published in Hormones and Cancer in the last decades have received a total of 8.1k indexed citations. Papers published in Hormones and Cancer usually cover Oncology (116 papers), Molecular Biology (113 papers) and Genetics (100 papers) specifically the topics of Estrogen and related hormone effects (88 papers), Prostate Cancer Treatment and Research (39 papers) and Cancer, Hypoxia, and Metabolism (35 papers). The most active scholars publishing in Hormones and Cancer are Julia C. Stingl, Solomon F.D. Paul, Hugh S. Taylor, Christopher I. Li, Jason G. Bromer, Zhou Yu-ping, Leo Doherty, Peter Thomas, Adriana C. Rodriguez and Kathryn A. Maurer.

In The Last Decade

Fields of papers published in Hormones and Cancer

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Hormones and Cancer. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Hormones and Cancer

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Hormones and Cancer. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Hormones and Cancer with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025